Drugs to foster kidney regeneration in experimental animals and humans

Nephron - Experimental Nephrology

Volumn 126, Issue 2, 2014, Pages 91-96

  Gagliardini, Elena ^a   Benigni, Ariela ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Angiotensin converting enzyme inhibitors; Kidney regeneration; Renal progenitors

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CHEMOKINE RECEPTOR CXCR4; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; STROMAL CELL DERIVED FACTOR 1; ANGIOTENSIN II; CXCL12 PROTEIN, HUMAN;

ARTICLE; BOWMAN CAPSULE; DRUG ACTIVITY; DRUG MECHANISM; GLOMERULOPATHY; GLOMERULOSCLEROSIS; HUMAN; KIDNEY DISEASE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; STEM CELL; TISSUE REGENERATION; CELL PROLIFERATION; DISEASE COURSE; DISEASE SEVERITY; ENZYME ACTIVATION; EXPERIMENTAL ANIMAL; KIDNEY INJURY; KIDNEY REGENERATION; MICROENVIRONMENT; NEPHROSCLEROSIS; PROGENITOR CELL LINE; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; RENAL PROTECTION; TREATMENT OUTCOME; TURNOVER TIME; ANIMAL; CYTOLOGY; DRUG EFFECTS; KIDNEY; PHYSIOLOGY; REGENERATION;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BOWMAN CAPSULE; CHEMOKINE CXCL12; HUMANS; KIDNEY; PODOCYTES; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, CXCR4; REGENERATION; STEM CELLS;

EID: 84901417396     PISSN: None     EISSN: 16602129     Source Type: Journal    
DOI: 10.1159/000360675     Document Type: Article

References (37)

1. Just PM, Riella MC, Tschosik EA, Noe LL, Bhattacharyya SK, de Charro F: Economic evaluations of dialysis treatment modalities. Health Policy 2008-86: 163-180.
2. Gridelli B, Remuzzi G: Strategies for making more organs available for transplantation. N Engl J Med 2000-343: 404-410.
3. Dinneen SF, Gerstein HC: The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus: a systematic overview of the literature. Arch Intern Med 1997-157: 1413-1418.
4. Perico N, Benigni A, Remuzzi G: Present and future drug treatments for chronic kidney diseases: evolving targets in renoprotection. Nat Rev Drug Discov 2008-7: 936-953.
5. Benigni A, Morigi M, Remuzzi G: Kidney regeneration. Lancet 2010-375: 1310-1317.
6. Remuzzi A, Gagliardini E, Sangalli F, Bonomelli M, Piccinelli M, Benigni A, Remuzzi G: ACE inhibition reduces glomerulosclerosis and regenerates glomerular tissue in a model of progressive renal disease. Kidney Int 2006-69: 1124-1130.
7. Ma LJ, Nakamura S, Whitsitt JS, Marcantoni C, Davidson JM, Fogo AB: Regression of sclerosis in aging by an angiotensin inhibitioninduced decrease in PAI-1. Kidney Int 2000-58: 2425-2436.
8. Boffa JJ, Lu Y, Placier S, Stefanski A, Dussaule JC, Chatziantoniou C: Regression of renal vascular and glomerular fibrosis: role of angiotensin II receptor antagonism and matrix metalloproteinases. J Am Soc Nephrol 2003-14: 1132-1144.
9. Adamczak M, Gross ML, Krtil J, Koch A, Tyralla K, Amann K, Ritz E: Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats. J Am Soc Nephrol 2003-14: 2833-2842.
10. Macconi D, Sangalli F, Bonomelli M, Conti S, Condorelli L, Gagliardini E, Remuzzi G, Remuzzi A: Podocyte repopulation contributes to regression of glomerular injury induced by ACE inhibition. Am J Pathol 2009-174: 797-807.
11. Benigni A, Morigi M, Rizzo P, Gagliardini E, Rota C, Abbate M, Ghezzi S, Remuzzi A, Remuzzi G: Inhibiting angiotensin-converting enzyme promotes renal repair by limiting progenitor cell proliferation and restoring the glomerular architecture. Am J Pathol 2011-179: 628-638.
12. Abbate M, Brown D, Bonventre JV: Expression of NCAM recapitulates tubulogenic development in kidneys recovering from acute ischemia. Am J Physiol 1999-277:F454-F463.
13. Appel D, Kershaw DB, Smeets B, Yuan G, Fuss A, Frye B, Elger M, Kriz W, Floege J, Moeller MJ: Recruitment of podocytes from glomerular parietal epithelial cells. J Am Soc Nephrol 2009-20: 333-343.
14. Gagliardini E, Corna D, Zoja C, Sangalli F, Carrara F, Rossi M, Conti S, Rottoli D, Longaretti L, Remuzzi A, Remuzzi G, Benigni A: Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes. Am J Physiol Renal Physiol 2009-297:F1448-F1456.
15. Zoja C, Corna D, Gagliardini E, Conti S, Arnaboldi L, Benigni A, Remuzzi G: Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotection. Am J Physiol Renal Physiol 2010-299:F1203-F1211.
16. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Lancet 1997-349: 1857-1863.
17. Ruggenenti P, Perna A, Benini R, Bertani T, Zoccali C, Maggiore Q, Salvadori M, Remuzzi G: In chronic nephropathies prolonged ACE inhibition can induce remission: dynamics of time-dependent changes in GFR. Investigators of the GISEN Group. Gruppo Italiano Studi Epidemiologici in Nefrologia. J Am Soc Nephrol 1999-10: 997-1006.
18. Wilmer WA, Hebert LA, Lewis EJ, Rohde RD, Whittier F, Cattran D, Levey AS, Lewis JB, Spitalewitz S, Blumenthal S, Bain RP: Remission of nephrotic syndrome in type 1 diabetes: long-term follow-up of patients in the Captopril Study. Am J Kidney Dis 1999-34: 308-314.
19. Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M: Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 1998-339: 69-75.
20. Ruggenenti P, Brenner BM, Remuzzi G: Remission achieved in chronic nephropathy by a multidrug approach targeted at urinary protein excretion. Nephron 2001-88: 254-259.
21. Ruggenenti P, Perticucci E, Cravedi P, Gambara V, Costantini M, Sharma SK, Perna A, Remuzzi G: Role of remission clinics in the longitudinal treatment of CKD. J Am Soc Nephrol 2008-19: 1213-1224.
22. Limesh M, Annigeri RA, Mani MK, Kowdle PC, Rao BS, Balasubramanian S, Seshadri R: Retarding the progression of chronic kidney disease with renin angiotensin system blockade. Indian J Nephrol 2012-22: 108-115.
23. Sagrinati C, Netti GS, Mazzinghi B, Lazzeri E, Liotta F, Frosali F, Ronconi E, Meini C, Gacci M, Squecco R, Carini M, Gesualdo L, Francini F, Maggi E, Annunziato F, Lasagni L, Serio M, Romagnani S, Romagnani P: Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys. J Am Soc Nephrol 2006-17: 2443-2456.
24. Rizzo P, Perico N, Gagliardini E, Novelli R, Alison MR, Remuzzi G, Benigni A: Nature and mediators of parietal epithelial cell activation in glomerulonephritides of human and rat. Am J Pathol 2013-183: 1769-1778.
25. Chade AR, Krier JD, Textor SC, Lerman A, Lerman LO: Endothelin-A receptor blockade improves renal microvascular architecture and function in experimental hypercholesterolemia. J Am Soc Nephrol 2006-17: 3394-3403.
26. Stewart N, Chade AR: Renoprotective effects of hepatocyte growth factor in the stenotic kidney. Am J Physiol Renal Physiol 2013-304:F625-F633.
27. Buelli S, Rosano L, Gagliardini E, Corna D, Longaretti L, Pezzotta A, Perico L, Conti S, Rizzo P, Novelli R, Morigi M, Zoja C, Remuzzi G, Bagnato A, Benigni A: Arrestin-1 drives endothelin-1-mediated podocyte activation and sustains renal injury. J Am Soc Nephrol 2014-25: 523-533.
28. Bruno S, Bussolati B, Grange C, Collino F, di Cantogno LV, Herrera MB, Biancone L, Tetta C, Segoloni G, Camussi G: Isolation and characterization of resident mesenchymal stem cells in human glomeruli. Stem Cells Dev 2009-18: 867-80.
29. Angelotti ML, Ronconi E, Ballerini L, Peired A, Mazzinghi B, Sagrinati C, Parente E, Gacci M, Carini M, Rotondi M, Fogo AB, Lazzeri E, Lasagni L, Romagnani P: Characterization of renal progenitors committed toward tubular lineage and their regenerative potential in renal tubular injury. Stem Cells 2012-30: 1714-1725.
30. Lindgren D, Bostrom AK, Nilsson K, Hansson J, Sjolund J, Moller C, Jirstrom K, Nilsson E, Landberg G, Axelson H, Johansson ME: Isolation and characterization of progenitorlike cells from human renal proximal tubules. Am J Pathol 2011-178: 828-837.
31. Gupta S, Verfaillie C, Chmielewski D, Kren S, Eidman K, Connaire J, Heremans Y, Lund T, Blackstad M, Jiang Y, Luttun A, Rosenberg ME: Isolation and characterization of kidney-derived stem cells. J Am Soc Nephrol 2006-17: 3028-3040.
32. Maeshima A, Yamashita S, Nojima Y: Identification of renal progenitor-like tubular cells that participate in the regeneration processes of the kidney. J Am Soc Nephrol 2003-14: 3138-3146.
33. Challen GA, Bertoncello I, Deane JA, Ricardo SD, Little MH: Kidney side population reveals multilineage potential and renal functional capacity but also cellular heterogeneity. J Am Soc Nephrol 2006-17: 1896-1912.
34. Hishikawa K, Marumo T, Miura S, Nakanishi A, Matsuzaki Y, Shibata K, Ichiyanagi T, Kohike H, Komori T, Takahashi I, Takase O, Imai N, Yoshikawa M, Inowa T, Hayashi M, Nakaki T, Nakauchi H, Okano H, Fujita T: Musculin/MyoR is expressed in kidney side population cells and can regulate their function. J Cell Biol 2005-169: 921-928.
35. Plotkin MD, Goligorsky MS: Mesenchymal cells from adult kidney support angiogenesis and differentiate into multiple interstitial cell types including erythropoietin-producing fibroblasts. Am J Physiol Renal Physiol 2006-291: F902-F912.
36. Pippin JW, Sparks MA, Glenn ST, Buitrago S, Coffman TM, Duffield JS, Gross KW, Shankland SJ: Cells of renin lineage are progenitors of podocytes and parietal epithelial cells in experimental glomerular disease. Am J Pathol 2013-183: 542-557.
37. Oliver JA, Klinakis A, Cheema FH, Friedlander J, Sampogna RV, Martens TP, Liu C, Efstratiadis A, Al-Awqati Q: Proliferation and migration of label-retaining cells of the kidney papilla. J Am Soc Nephrol 2009-20: 2315-2327.